The global perspective of mutation distribution revealed that both the high and low CCDC43 groups had a high prevalence of mutations in the cellular tumor antigens p53 (TP53), titin (TTN), and catenin beta 1 (CTNNB1) (Figures 4A, B). This evidence concerns the gene TP53 and neoplasm.